Evergreen Capital Management LLC Boosts Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Evergreen Capital Management LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,268 shares of the medical equipment provider’s stock after purchasing an additional 112 shares during the quarter. Evergreen Capital Management LLC’s holdings in Intuitive Surgical were worth $2,228,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Bennett Selby Investments LP lifted its position in Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after acquiring an additional 17 shares during the period. Onefund LLC boosted its position in shares of Intuitive Surgical by 1.9% in the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock worth $494,000 after purchasing an additional 18 shares in the last quarter. LVW Advisors LLC increased its position in Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after buying an additional 19 shares in the last quarter. Wesbanco Bank Inc. boosted its holdings in Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after acquiring an additional 19 shares in the last quarter. Finally, Journey Strategic Wealth LLC increased its holdings in shares of Intuitive Surgical by 1.9% during the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock valued at $542,000 after acquiring an additional 19 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. Bernstein Bank raised their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Evercore ISI increased their target price on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Erste Group Bank downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. Robert W. Baird decreased their target price on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a research report on Tuesday, March 18th. Finally, UBS Group boosted their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $611.81.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 33,754 shares of company stock worth $17,691,621. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $482.74 on Friday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm has a fifty day moving average price of $524.41 and a 200-day moving average price of $532.04. The stock has a market cap of $171.94 billion, a PE ratio of 75.31, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.